Synthesis and biological evaluation of novel EG5 inhibitors

Zitieren

Dateien zu dieser Ressource

Dateien Größe Format Anzeige

Zu diesem Dokument gibt es keine Dateien.

SARLI, Vasiliki, Stefan HUEMMER, Nils SUNDER-PLASSMANN, Thomas MAYER, Athanassios GIANNIS, 2005. Synthesis and biological evaluation of novel EG5 inhibitors. In: ChemBioChem. 6(11), pp. 2005-2013. ISSN 1439-4227. Available under: doi: 10.1002/cbic.200500168

@article{Sarli2005-11Synth-14044, title={Synthesis and biological evaluation of novel EG5 inhibitors}, year={2005}, doi={10.1002/cbic.200500168}, number={11}, volume={6}, issn={1439-4227}, journal={ChemBioChem}, pages={2005--2013}, author={Sarli, Vasiliki and Huemmer, Stefan and Sunder-Plassmann, Nils and Mayer, Thomas and Giannis, Athanassios} }

<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/rdf/resource/123456789/14044"> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:contributor>Huemmer, Stefan</dc:contributor> <dcterms:rights rdf:resource="http://nbn-resolving.org/urn:nbn:de:bsz:352-20140905103605204-4002607-1"/> <dc:creator>Huemmer, Stefan</dc:creator> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dc:language>eng</dc:language> <dc:creator>Sarli, Vasiliki</dc:creator> <dcterms:issued>2005-11</dcterms:issued> <dc:contributor>Mayer, Thomas</dc:contributor> <dcterms:title>Synthesis and biological evaluation of novel EG5 inhibitors</dcterms:title> <dc:creator>Mayer, Thomas</dc:creator> <dc:contributor>Sarli, Vasiliki</dc:contributor> <dc:contributor>Giannis, Athanassios</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-11T09:20:26Z</dcterms:available> <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/14044"/> <dc:creator>Sunder-Plassmann, Nils</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/rdf/resource/123456789/28"/> <dc:rights>deposit-license</dc:rights> <dc:contributor>Sunder-Plassmann, Nils</dc:contributor> <dcterms:bibliographicCitation>Publ. in: Chembiochem ; 6 (2005), 11. - S. 2005-2013</dcterms:bibliographicCitation> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-01-11T09:20:26Z</dc:date> <dcterms:abstract xml:lang="eng">Human Eg5 is a mitotic kinesin that is essential for bipolar spindle formation and maintenance during mitosis. Recently, the discovery of compounds that inhibit Eg5 and cause mitotic arrest has attracted great interest, due to their potential use as the next generation of antimitotics. Here, we present the synthesis and biological investigation of 3,4-dihydrophenylquinazoline-2(1H)-thiones as selective and potent Eg5 inhibitors.</dcterms:abstract> <dc:creator>Giannis, Athanassios</dc:creator> </rdf:Description> </rdf:RDF>

Das Dokument erscheint in:

KOPS Suche


Stöbern

Mein Benutzerkonto